Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Covid-19

May 22, 2020 Pharma applications / Uncategorized

First copies of Gilead’s SBECD-enabled remdesivir to start selling in Bangladesh

According to Hindustan Times, Bangladesh’s Beximco Pharmaceuticals Ltd. has become the world’s first company to start selling the generic version

Continue reading

May 19, 2020 CD as API

Cholesterol and COVID19 lethality in elderly

A new study published on the preprint server bioRxiv* in May 2020 suggests that the strikingly increased mortality in COVID-19 patients who

Continue reading

May 14, 2020 Pharma applications

Coronavirus and COVID-19: The latest news and views from the scientific community about the new coronavirus and Covid-19

Coronavirus is a family of viruses that cause respiratory infections.The new coronavirus agent was discovered on 12/31/19 after cases registered

Continue reading

May 13, 2020 CD derivatives / Pharma applications

Voluntary Licensing Agreements for Remdesivir

Gilead has signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers based in India and Pakistan to further expand

Continue reading

May 8, 2020 CD derivatives / Pharma applications / Uncategorized

Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19

Japan approved the Gilead Sciences antiviral drug remdesivir Thursday for treatment of severe COVID-19 patients, under an exceptional approval pathway

Continue reading

May 8, 2020 CD as API / CD derivatives / Pharma applications / Uncategorized

UC Berkeley, Excivion and CycloLab develop antiviral cyclodextrins against SARS-CoV-2

UC Berkeley, Excivion and Cyclolab announce a supplemental grant awarded to UC Berkeley by the National Institutes of Health to evaluate a wide

Continue reading

May 7, 2020 Pharma applications / Uncategorized

Gilead outlines plans to distribute COVID-19 drug worldwide

Gilead on Tuesday said it is negotiating with overseas drug manufacturers to license its SBECD-enabled coronavirus treatment remdesivir in an effort

Continue reading

May 2, 2020 CD derivatives / Pharma applications / Uncategorized

SBECD-enabled Remdesivir Receives FDA’s Emergency Use Authorization for the Treatment of COVID-19

Gilead Sciences, Inc. yesterday announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for

Continue reading

April 29, 2020 CD derivatives / Pharma applications

Gilead’s Remdesivir meets main goal of trial in COVID-19 patients

Gilead Sciences today announced that preliminary results of a coronavirus drug trial showed at least 50% of patients treated with

Continue reading

April 29, 2020 CD as API / Pharma applications

Like soap for the patient’s mouth—cyclodextrins are important for future of oral care

Dental Tribune, the European blog of dentists published a post on the possible application of cyclodextrins as a mouth rinse

Continue reading

Posts pagination

«Previous Posts 1 … 11 12 13 14 Next Posts»

Recent Posts

  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • New Hungarian Medicine on the Horizon?
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (442)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (831)
  • E-ducation (64)
  • Environmental (144)
  • Events (242)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,240)
  • Supramolecular systems (45)
  • Uncategorized (174)

Top Posts

  • New Hungarian Medicine on the Horizon?
  • Chapter 3: Professor Casu and Cyclodextrins
  • Novel medicament comprising fosaprepitant/SBECD has been approved.
  • Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19
  • New book on beta-cyclodextrin and its derivatives
  • A Novel In Situ Gelling System of Quercetin/Sulfobutyl-Ether-β-Cyclodextrin Complex-Loaded Chitosan Nanoparticles for the Treatment of Vulvovaginitis
  • Wound dressing based on PVP/PVA nanofibers containing β-cyclodextrin/curcumin complex
  • Oculis aces the Phase 2 clinical trial for OCS-01 treating DME
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • Nature.com: HPBCD treatment improves learning and executive function in Alzheimer model mice

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...